Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

HCM HUTCHMED China Limited

21,71

0,89 (4,27%)

Dernière mise à jour : 16:54:33

Retardé de 15 minutes

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

0001104659-24-028454.txt

HUTCHMED China (NASDAQ:HCM)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024

Plus de graphiques de la Bourse HUTCHMED China

HUTCHMED China (NASDAQ:HCM)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024

Plus de graphiques de la Bourse HUTCHMED China

Actualités HUTCHMED China Limited

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
Mercredi 8 Mai 2024 ( il y a 2 jours) • GlobeNewswire Inc.

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
Vendredi 26 Avril 2024 ( il y a 2 semaines) • GlobeNewswire Inc.

HUTCHMED Highlights Data to be Presented at AACR Congress 2024
Vendredi 5 Avril 2024 ( il y a 1 mois) • GlobeNewswire Inc.

HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
Mardi 2 Avril 2024 ( il y a 1 mois) • GlobeNewswire Inc.

HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC
Jeudi 28 Mars 2024 ( il y a 1 mois) • GlobeNewswire Inc.

HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
Vendredi 22 Mars 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mardi 5 Mars 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mercredi 28 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mercredi 28 Février 2024 ( il y a 2 mois) • Edgar (US Regulatory)

HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
Mercredi 28 Février 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mercredi 7 Février 2024 ( il y a 3 mois) • Edgar (US Regulatory)

HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session
Mercredi 7 Février 2024 ( il y a 3 mois) • GlobeNewswire Inc.

Plus d'articles sur HUTCHMED China Limited

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales